Our leadership team is committed to addressing compelling medical needs
Our Board is comprised of experienced directors who provide relationships and oversight to the company.
Our team of scientific experts and specialists ensure we stay at the forefront of innovation
Our unique mechanism of action is complimentary to existing therapies and applicable to many cancer indications
We are progressing on several trials aimed at treating various cancer types
NeuVax is currently in several ongoing Phase 2 investigator sponsored trials.
Multiple clinical trials have been completed to enable initiation of a Phase 3 clinical trial.
Cancer types our therapy targets
Information on how to enroll in our clinical trials
We partner with pre-eminent cancer centers and organizations to help realize our vision
15 W. 38th Street, 10th FloorNew York, NY, 10018917-438-4353